Drug-price negotiation could survive a Trump-Vance administration
Republicans have consistently bashed the new authority allowing Medicare to negotiate drug prices, but repealing it could be a challenge.
Sen. J.D. Vance boards "Trump Force Two" at Roanoke-Blacksburg Regional Airport after a campaign rally in Roanoke, Va., on Monday. (AP Photo/Julia Nikhinson)
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.
